Inovio Pharmaceuticals Inc vs KraneShares Hang Seng TECH Index ETF — how do they compare? Inovio Pharmaceuticals Inc trades at $0.77 (market cap $76.09M), while KraneShares Hang Seng TECH Index ETF trades at $13.5. The key difference: KraneShares Hang Seng TECH Index ETF is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| INO | KTEC | |
|---|---|---|
Market Cap | $76.09M | — |
Sector | Health | Sector/Thematic |
52-Week High | $2.87 | $19.51 |
52-Week Low | $0.66 | $12.00 |
Enterprise Value | $47.10M | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
KTEC trades at $13.78, up 1.47% today, with a bullish technical signal driven by moving averages. Support and resistance cluster at $14, indicating a critical price zone. Financial ratios are unavailable, limiting fundamental clarity. Recent news highlights China's AI competition as a potential catalyst for tech ETFs like KTEC.
The stock's outlook hinges on AI sector momentum, but risks include reliance on thematic trends and lack of disclosed financials. Upside depends on broader tech ETF inflows, while volatility from geopolitical or market shifts poses a near-term challenge.
Trailing returns across standard periods
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →KTEC tracks the Hang Seng TECH Index, providing targeted exposure to the 30 largest technology companies listed on the Hong Kong Stock Exchange. It focuses on innovative, internet-based businesses across sectors like e-commerce, fintech, cloud computing, and digital technology.
Read more on KTEC →